Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Podcast | Sexual health in older age

Dr Holly Thomas helps us unpack the needlessly taboo subject of sex and sexual health in women of older age.

Listen now
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in:

Open Access 05-02-2025 | Infectious Pulmonary Diseases | Case Report

Cupriavidus gilardii infection following heart failure: a case report and literature review

Authors: Yanwen Liu, Jianxin Gao, Jingyun Ye, Hui Han, Haiyan Zhu

Published in: BMC Infectious Diseases | Issue 1/2025

Login to get access

Abstract

Background

Cupriavidus gilardii is a species of the genus Cupriavidus. Knowledge about the pathogenic characteristics of Cupriavidus gilardii is limited, especially cardiac infection with this bacterium has not been reported.

Case presentation

We encountered a case of pulmonary infection after myocardial infarction and heart failure. The initial empirical treatment with meropenem was ineffective. After cultured Cupriavidus gilardii, cefoperazone sulbactam and minocycline were used, and the infection and heart failure was improved for few days. Unfortunately, the patient eventually died of heart failure exacerbated by infection with Staphylococcus Epidermidis.

Conclusion

Meropenem has a limited therapeutic effect on this bacterium. Monitoring heart function and selecting effective antibiotics are crucial for improving the prognosis of patients suffered from heart disease and Cupriavidus gilardii infection.
Appendix
Available only for authorised users
Literature
1.
Cherak Z, Loucif L, et al. MCR-5-Producing colistin-resistant Cupriavidus gilardii strain from Well Water in Batna. Algeria mSphere. 2021;6(5):e0057521.CrossRefPubMed
2.
De La Rosa- Acosta M, Jiménez-Collazo J, et al. Bacteria as potential indicators of Heavy Metal Contamination in a Tropical Mangrove and the implications on Environmental and Human Health. J Trop Life Sci. 2015;5(3):110–6.CrossRef
3.
Harmon DE, Miranda OA et al. Prevalence and characterization of carbapenem-resistant bacteria in water bodies in the Los Angeles-Southern California area. MicrobiologyOpen 2018;8:e00692.
4.
Hou H, Wang Y, et al. The role of RIP3 in cardiomyocyte necrosis induced by mitochondrial damage of myocardial ischemia-reperfusion. Acta Biochim Biophys Sin (Shanghai). 2018;50(11):1131–40.CrossRefPubMed
5.
Lafi FF, Bokhari A et al. Draft genome sequence of the plant growth-promoting Cupriavidus gilardii strain JZ4 isolated from the Desert Plant Tribulus terrestris. Genome Announcements (Washington DC) 2016;4(4).
6.
Pei Z, Yao W, et al. Regulation of sirtuins in Sepsis-Induced myocardial damage: the underlying mechanisms for Cardioprotection. Front Biosci (Landmark Ed). 2024;29(2):54.CrossRefPubMed
7.
Peng Q, Yang Q. Risk factors and management of pulmonary infection in elderly patients with heart failure: a retrospective analysis. Med (Baltim). 2021;100(38):e27238.CrossRef
8.
Ruiz C, McCarley A et al. Comparative Genomics Reveals a Well-Conserved Intrinsic Resistome in the Emerging Multidrug-Resistant Pathogen Cupriavidus gilardii. mSphere 2019, 4(5).
9.
Tanaka R, Nouzaki K, et al. Activated sludge microbiome in a membrane bioreactor for treating Ramen noodle-soup wastewater. J Gen Appl Microbiol. 2021;66(6):339–43.CrossRefPubMed
10.
Wang X, Chen M, et al. Genome sequence analysis of the Naphthenic Acid Degrading and Metal Resistant Bacterium Cupriavidus gilardii CR3. PLoS ONE. 2015;10(8):e0132881.CrossRefPubMedPubMedCentral
11.
Wu X, Wang W, et al. Rapid Biodegradation of the Herbicide 2,4-Dichlorophenoxyacetic acid by Cupriavidus gilardii T-1. J Agric Food Chem. 2017;65(18):3711–20.CrossRefPubMed
Metadata
Title
Cupriavidus gilardii infection following heart failure: a case report and literature review
Authors
Yanwen Liu
Jianxin Gao
Jingyun Ye
Hui Han
Haiyan Zhu
Publication date
05-02-2025
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2025
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-025-10519-z

Other articles of this Issue 1/2025

Fecal carriage of carbapenemase and AmpC-β-lactamase producers among extended spectrum β-Lactamase-producing E. coli and Klebsiella spp. isolates in patients attending hospitals

  • Open Access
  • Research

Time trend and identification of risk areas for physical disability due to leprosy in Brazil: An ecological study, 2001-2022

Lateral-flow device for the diagnosis of invasive aspergillosis: a systematic review and diagnostic meta-analysis

A novel malaria mathematical model: integrating vector and non-vector transmission pathways

  • Open Access
  • Research

Prevalence and multidrug resistance patterns of bacterial pathogens in wastewater and drinking water systems from hospital and non-hospital environments in Ethiopia: a systematic review and meta-analysis

Stigma of People Affected by Leprosy and its determinants: a cross-sectional study in Sri Lanka

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now
Video

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases
Image Credits